Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

FDA approves Neuralstem's IND to initiate NSI-189 Phase Ia safety trial in major depression

Neuralstem, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.

17 Dec 2010

Recordati, Nymox sign European licensing agreement for BPH investigational drug, NX-1207

Recordati and Nymox Pharmaceutical Corporation announced today the signing of a European licensing agreement for the development and commercialization of NX-1207, Nymox's Phase III investigational drug currently in clinical development in the U.S. for the treatment of benign prostatic hyperplasia (BPH).

17 Dec 2010

Second brain death exam impacts organ donation rates

Requiring a second exam on a person who is considered brain dead may be unnecessary, according to a study on the impact of a second brain death exam on organ donation rates. The research is published in the December 15, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

16 Dec 2010

Adeona expands and enhances zinc-based product candidate portfolio

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it has acquired access to clinical data supporting a zinc-based therapy for the prevention of infections in the elderly. This acquisition expands and enhances Adeona's zinc-based product candidate portfolio that already includes its proprietary zinc-based tablets for use in the dietary management of mild to moderate Alzheimer's disease and mild cognitive impairment patients, and age-related macular degeneration.

16 Dec 2010

Alzheimer's Foundation of America praises House, Senate passage of National Alzheimer's Project Act

The Alzheimer's Foundation of America issued this statement today regarding passage of the National Alzheimer's Project Act. The National Alzheimer's Project Act would create the National Alzheimer's Project, which would coordinate government efforts to prevent and treat the disease and create a national strategy for defeating Alzheimer's disease.

16 Dec 2010

Pico-Tesla commences pilot study of Magneceutical Therapy in fibromyalgia patients

Pico-Tesla, The Magneceutical® Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have fibromyalgia. The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.

16 Dec 2010

Perirhinal cortex critical for forming unconscious conceptual memories

A small area deep in the brain called the perirhinal cortex is critical for forming unconscious conceptual memories, researchers at the UC Davis Center for Mind and Brain have found.

16 Dec 2010

New study records show dementia residents seek hospice benefit

A new study of nursing home records shows more residents with dementia are seeking a hospice benefit and using it longer. The study also estimates that 40 percent of nursing home residents die with some degree of dementia.

16 Dec 2010

Neuroscientist explains how to use hoppocampus to reduce risk of dementia

Véronique Bohbot, PhD., neuroscientist at the Douglas Mental Health University Institute and associate professor at McGill University, leads studies on navigational strategies. She presented her findings at the recent meeting of the Society for Neuroscience in San Diego, which could bring light into how we can make better use of our hippocampus in order to reduce the risk of dementia.

16 Dec 2010

USAgainstAlzheimer's applauds House passage of National Alzheimer's Project Act

USAgainstAlzheimer's today applauded the passage by the House of Representatives of the National Alzheimer's Project Act and released statements from its Chairman and Founder George Vradenburg, its Scientific Advisory Board Chair and Nobel Laureate Stanley Prusiner and its ally in the Alzheimer's Movement, First Lady of California Maria Shriver.

16 Dec 2010

Synthetic derivative of curry spice can be effective neuroprotective for stroke and TBI

A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.

16 Dec 2010

Researchers examine expression of toxic mRNA in patients with Fragile X Tremor Ataxia Syndrome

Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.

15 Dec 2010

New hypothesis emphasizes the value of anti-inflammatory approaches to prevent Alzheimer's disease

Karl Herrup thinks that the national research effort to understand Alzheimer-s disease has gone about as far as it can go with its current theories.

15 Dec 2010

Case study sheds light on pathological course of Alzheimer's disease

A case study from the Swedish medical university Karolinska Institutet sheds light on the pathological course of Alzheimer's disease. The brain of the first Alzheimer's patient to display amyloids demonstrable with a PET scanner has been studied, both during progression of the disease and after death.

15 Dec 2010

BRIC researchers discover new protein that improves immune system

Researchers at BRIC, the University of Copenhagen, have discovered for the first time a protein normally found in the body that can act to prevent chronic tissue inflammation.

15 Dec 2010

Over expression of transcription factor improves neurological function in HD transgenic mice models

Over expressing a transcription factor that promotes the increase in number of mitochondria greatly improves the neurological function of transgenic mice models for Huntington's disease, researchers today told the American Society of Cell Biology's 50th Annual Meeting in Philadelphia.

15 Dec 2010

DBS targets same class of neuronal cells that respond to physical exercise and drug Prozac

Shooting steady pulses of electricity through slender electrodes into a brain area that controls complex behaviors has proven to be effective against several therapeutically stubborn neurological and neuropsychiatric disorders. Now, a new study has found that this technique, called deep brain stimulation (DBS), targets the same class of neuronal cells that are known to respond to physical exercise and drugs such as Prozac.

15 Dec 2010

Neuropeptide S protein boosts memory

UC Irvine researchers have identified a novel mechanism in the brain that boosts memory.

15 Dec 2010

Study: HUCBs boost survival and maturation of hippocampal neurons

Laboratory culture studies examining the activity of human umbilical cord blood cells on experimental models of central nervous system aging, injury and disease, have shown that HUCBs provide a 'trophic effect' that enhances survival and maturation of hippocampal neurons harvested from both young and old laboratory animals.

15 Dec 2010

Alzheimer Society applauds House of Commons motion calling on government to address dementia in Canada

The Alzheimer Society of Canada applauds a motion passed Friday by the House of Commons calling on the Federal Government to "address the rising financial and human costs of Alzheimer's disease and other forms of dementia in Canada."

14 Dec 2010

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

FDA approves Neuralstem's IND to initiate NSI-189 Phase Ia safety trial in major depression

Recordati, Nymox sign European licensing agreement for BPH investigational drug, NX-1207

Second brain death exam impacts organ donation rates

Adeona expands and enhances zinc-based product candidate portfolio

Alzheimer's Foundation of America praises House, Senate passage of National Alzheimer's Project Act

Pico-Tesla commences pilot study of Magneceutical Therapy in fibromyalgia patients

Perirhinal cortex critical for forming unconscious conceptual memories

New study records show dementia residents seek hospice benefit

Neuroscientist explains how to use hoppocampus to reduce risk of dementia

USAgainstAlzheimer's applauds House passage of National Alzheimer's Project Act

Synthetic derivative of curry spice can be effective neuroprotective for stroke and TBI

Researchers examine expression of toxic mRNA in patients with Fragile X Tremor Ataxia Syndrome

New hypothesis emphasizes the value of anti-inflammatory approaches to prevent Alzheimer's disease

Case study sheds light on pathological course of Alzheimer's disease

BRIC researchers discover new protein that improves immune system

Over expression of transcription factor improves neurological function in HD transgenic mice models

DBS targets same class of neuronal cells that respond to physical exercise and drug Prozac

Neuropeptide S protein boosts memory

Study: HUCBs boost survival and maturation of hippocampal neurons

Alzheimer Society applauds House of Commons motion calling on government to address dementia in Canada

Innovation in neuroscience drug discovery - eBook eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in